To Convert or Not to Convert? Official International Association of Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Considerations and Recommendations for Converting Capillary Blood Microsampling Concentrations to Plasma Concentrations

Key points include the importance of conducting a comprehensive clinical validation study to fully understand capillary blood microsampling results. In addition, the performance of the conversion method should be evaluated case by case, as it depends on both the microsampling-based method and analyte of interest. Furthermore, an independent set of paired capillary and venous samples should be used to validate an established conversion formula. Finally, a key point for future studies is to focus on the clinical impact of (converted) capillary blood concentrations in comparison with decisions based on results in the reference matrix to guarantee any microsampling-based outcome.

Authors

Institutions

Publication Details

Journal
Therapeutic Drug Monitoring
Published
2025-11-05
DOI
https://doi.org/10.1097/ftd.0000000000001393
Citations
4
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
3.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

To Convert or Not to Convert? Official International Association of Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Considerations and Recommendations for Converting Capillary Blood Microsampling Concentrations to Plasma Concentrations

Jan‐Willem C. Alffenaar, Anders Åsberg, Liesl Heughebaert, Laura Boffel et al.
4 citations
Therapeutic Drug Monitoring
Biosimilars and Bioanalytical Methods
3.19
article

To Convert or Not to Convert? Official International Association of Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Considerations and Recommendations for Converting Capillary Blood Microsampling Concentrations to Plasma Concentrations

Jan‐Willem C. Alffenaar, Anders Åsberg, Liesl Heughebaert, Laura Boffel, Theo Rispens, Dirk Jan A. R. Moes, Annick de Vries, Brenda C. M. de Winter, Maria Shipkova, Christophe Pol Stove, Hanna De Baets
article en
4 citations

Abstract

Key points include the importance of conducting a comprehensive clinical validation study to fully understand capillary blood microsampling results. In addition, the performance of the conversion method should be evaluated case by case, as it depends on both the microsampling-based method and analyte of interest. Furthermore, an independent set of paired capillary and venous samples should be used to validate an established conversion formula. Finally, a key point for future studies is to focus on the clinical impact of (converted) capillary blood concentrations in comparison with decisions based on results in the reference matrix to guarantee any microsampling-based outcome.

Therapeutic Drug MonitoringVol. 48(1)
Oslo University Hospital (NO), The University of Sydney (AU), University of Oslo (NO), Leiden University Medical Center (NL), Erasmus MC (NL), Westmead Hospital (AU), Sanquin (NL), Ghent University (BE), Netherlands Center for Occupational Diseases (NL), BioScientia (Poland) (PL), Vrije Universiteit Amsterdam (NL)
Openalex Percentile: Top 7%
Biosimilars and Bioanalytical Methods
3.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.